Skip to content

Haem-Fit: Exercise and Wellness Program for Haematology Cancer patients

Haem-Fit: A 3 month intervention trial to assess patient adherence and maintenance of muscle mass by implementing an exercise and wellness program for haematology cancer patients in hospital for 7 days or more

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000172202
Enrollment
13
Registered
2018-02-02
Start date
2018-02-27
Completion date
2018-05-22
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this research is to test an exercise and wellness program for haematology in-patients receiving cancer treatment. Who is it for? You may be eligible for this study if you are undergoing treatment for a haematological malignancy at the Calvary Mater Newcastle Hospital which requires you to be in hospital for at least 7 days. Study details Each participant will be assessed by a physiotherapist (face to face) and provided with a personalised exercise program (30-60 minutes duration of strength and balance + walking) tailored to be performed daily while in hospital. Each participant will also be given written information on diet, nutrition, and exercise. This study will help to determine adherence and satisfaction of patients and staff to a personalised exercise program while in hospital.

Interventions

Each participant will be assessed by a physiotherapist (face to face) and provided with an exercise program. This initial assessment will take approximately 30-60 minutes depending on patient needs, but it will not be time restricted. Each patient will be provided with an exercise routine of 10-15 minutes duration that combines simple exercises for maintaining strength and balance and is tailored to their personal fitness levels and health circumstances.. They will be expected to perform the ro

Each participant will be assessed by a physiotherapist (face to face) and provided with an exercise program. This initial assessment will take approximately 30-60 minutes depending on patient needs, but it will not be time restricted. Each patient will be provided with an exercise routine of 10-15 minutes duration that combines simple exercises for maintaining strength and balance and is tailored to their personal fitness levels and health circumstances.. They will be expected to perform the routine at least once per day, plus additional time (at least 10 minutes) walking. The level of intensity should be about 3-4 (slight shortness of breath) on the 10 point modified Borg Scale. Tailored exercises will be necessary to account for patients with central or PICC lines, receiving chemotherapy, or suffering low blood counts. Five different alternating exercises will be prescribed to be preformed at least once daily while in hospital. Ward nurses will be trained to assist with monitoring correct performance of the exercises. Subsequent referral to a physiotherapist can be made at any time as per normal standard of care. Each participant will also be given written information on diet, nutrition, and exercise. These resources have been specifically designed for the study and will not be made available to non-study participants. Participants will be asked to keep a diary to assess adherence.

Sponsors

Calvary MAter Newcastle Hunter Haematology Unit
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

all hematology cancer patient admissions with 7 or more days anticipated length of stay

Exclusion criteria

• People with artificial electrical implants such as a defibrillator or pacemaker will be excluded due to inability to undergo impedance bodycomposition testing • Inability to communicate in English

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026